Yen-Ju Heald

Yen-Ju Heald is a Senior Associate Scientist currently at AvenCell since July 2022, previously holding the same title at Vor Biopharma from September 2020 to July 2022, after serving as an Associate Scientist there. Prior experience includes a role as a Senior Research Associate at Intellia Therapeutics, Inc. from May 2019 to September 2020, focusing on the design and development of AAVs and editing testing for Duchenne muscular dystrophy. Earlier positions include Research Specialist at UChicago Medicine, where in vitro development of drug-resistant ovarian cancer cell lines was conducted, and Research Assistant at Purdue University, where biomolecular methods were employed to determine drug target specificity. Yen-Ju also served as a Teaching Assistant, leading lab lectures in botany. Initial research experience was at National Taiwan University, analyzing virus interactions with plants. Yen-Ju holds a Master of Science in Botany/Plant Biology from Purdue University and a Bachelor's degree in the same field from National Taiwan University.